BioMarin Pharmaceutical Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving BioMarin Pharmaceutical Inc. now
Current reporting with the operating signal separated from the noise.
BioMarin Pharmaceutical Inc.
The story matters when it changes BioMarin Pharmaceutical Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.BioMarin Pharmaceutical Inc. (BMRN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
The story matters when it changes BioMarin Pharmaceutical Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2025 Earnings Call Transcript
Investors are testing whether BioMarin Pharmaceutical Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory
The story matters when it changes BioMarin Pharmaceutical Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Why BioMarin Pharmaceutical Inc. (BMRN) Is Among the Best Healthcare Stocks To Buy According to Analysts
Investors are testing whether BioMarin Pharmaceutical Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
Investors are testing whether BioMarin Pharmaceutical Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest BMRN filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
BioMarin Pharmaceutical Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →